Q1 2019 Novozymes A/S Earnings Call Transcript
/-&
Good morning, and welcome to the Novozymes Conference Call. Today, we'll review our performance for the first 3 months of 2019 as well as the outlook and key priorities for the year. Our presentation should take around 20-25 minutes, and after that, we'll take your questions.
My name is Peder Holk Nielsen. I'm the CEO of Novozymes. I'm joined here today by the Executive Leadership Team and Investor Relations.
Please turn to Slide #2. We had a 4% decline in organic sales in the first quarter. While most industries delivered according to expectations, our Bioenergy business came in below. The U.S. ethanol business was more challenged than we expected. The slowdown in ethanol production was a bit larger than anticipated, and on top of that floods in the U.S. Midwest from mid-March and onwards made the tough situation even worse. It continues to affect our sales into April. Like other ag and ag service companies have announced, Novozymes does not expect to recover the lost sales.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |